World-class multidisciplinary partnership to take science one step closer to building fully functional organs at lightning speed

In the European project ENLIGHT, researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication. More>>

SPT Labtech acquires BioMicroLab

Deal strategically expands SPT Labtech’s offering in sample management for life sciences

SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, announces the acquisition of BioMicroLab, a robotics automation provider for life science laboratories. More>>

NovalGen Enters Strategic Partnership with HALIX B.V. to Manufacture Clinical Trial Materials

NovalGen Ltd. (“NovalGen”), a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V. (“HALIX”), a contract development and manufacturing organisation, today announced a strategic partnership. Within the scope of this partnership, HALIX will provide manufacturing of clinical supply of NovalGen’s therapies. More>>

Catalent Announces Commercial Supply Agreement with Aurinia Pharmaceuticals for Newly-Approved LUPKYNIST Softgels

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it recently signed a multi-year commercial supply agreement with Aurinia Pharmaceuticals. More>>

PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 for the Treatment of COVID-19

PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced the initiation of the second stage of the FITE19 clinical trial to assess PTC299 in COVID-19 patients. PTC299 is an oral investigational drug with a novel dual mechanism of action that has the potential to inhibit viral replication and attenuate the uncontrolled inflammatory response that ensues after infection. More>>

Theravectys Announces $20M Funding Round

Funding to drive Phase 1 and 1-2 Clinical Trials for COVID-19, HPV induced cancers and HBV Vaccine Candidates

THERAVECTYS, the world leading pioneer in lentiviral vector technology, announced today a fully subscribed $20M funding round. This funding will be used to progress the Theravectys pipeline by driving several vaccine candidates, including their COVID vaccine, into phase 1 and 1-2 clinical trials. More>>

Vetter continues its successful performance at the 2021 CMO Leadership Awards

Ravensburg, Germany, February 18, 2021 – Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), was granted the 2021 CMO Leadership Awards in five core categories – quality, expertise, compatibility, capabilities, and service. The award, now in its tenth year, was given by the leading trade press publication, Life Science Leader. Vetter was also the recipient of the award in a variety of categories in previous years. More>>

Sonoco ThermoSafe Celebrates First Pegasus ULD® Uplift on AirBridgeCargo Airlines, Releases Case Study

ARLINGTON HEIGHTS, Ill., Feb. 08, 2021 -- Sonoco ThermoSafe, a unit of Sonoco (NYSE:SON) and the leading global provider of temperature assurance packaging for life sciences and healthcare, and AirBridgeCargo Airlines, an all-cargo carrier within the Volga-Dnepr Group, have successfully conducted a test shipment with ThermoSafe’s new Pegasus ULD®, the world’s first passive bulk temperature controlled container for pharmaceutical use that is an approved unit load device. More>>

Aptar’s Activ-Film™ Technology Selected to Protect New SARS Rapid Antigen Test for COVID-19 Diagnosis

Crystal Lake, Illinois, February 16, 2021 - AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced that its Activ-Film™ technology was selected to protect a new SARS Rapid Antigen test for COVID-19 that recently received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). More>>

Medidata Launches Sensor Cloud, Ushering in Next Generation Solution for Connected Devices and Wearable Sensors in Clinical Trials

Unified solution simplifies and expedites sensor integration, data ingestion and analysis, and digital biomarker discovery New technology will generate intelligent insights and help improve clinical outcomes More>>